Oragenics Statistics
NYSE: OGENHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.463-0.0369 (-7.38%)
At close: Oct 8, 3:59 PM ET · Delayed 15 min
Pre-market: 0.453 -2.16%
Oragenics by the numbers
Oragenics has a market capitalization of $2.1 million based on 4.51M shares outstanding. With trailing EPS of $-2.44, Oragenics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.6% below its 50-day average and 27.8% below its 200-day average.
Average daily trading volume is 29.43K shares, or about $13,627 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
OGEN valuation vs. peer median
| Metric | OGEN | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.09M | $2.27M | -8% |
| Avg. volume | 29.43K | 638.96K | -95% |
Peer median across 8 companies: GNPX, TCRT, LABT, SBFM, ARTL, PPBT, ELAB, SPRC.
Valuation
- Market cap
- $2.09M
- EPS (TTM)
- $-2.44
- Shares outstanding
- 4.51M
Price and trading
- Previous close
- 0.4999
- Open
- 0.495
- Day range
- 0.463 – 0.50
- 52-week range
- 0.46 – 1.45
- 50-day moving average
- 0.5124
- 200-day moving average
- 0.6416
- Beta
- —
- Volume
- 45.80K
- Average volume
- 29.43K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 2.09M
- Forward Pe
- -0.04
- Eps
- -2.44
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.45
- Week52 Low
- 0.46
- Avg Volume
- 29,432.00
- Shares Outstanding
- 4.51M
- Ma50
- 0.51
- Ma200
- 0.64
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -68.07%
- Pct From52w Low
- 0.65%